{"chunk_id": "_Drugs-in-Pregnancy-and-Lactation--Improved-Benefit-Risk-Information_-January-22--2015-Issue__chunk_13", "source": "_Drugs-in-Pregnancy-and-Lactation--Improved-Benefit-Risk-Information_-January-22--2015-Issue", "text": "arely available at the \ntime a drug is first approved. However, data may become available from various sources, including well -conducted studies \npublished in the medical literature about the use of prescription drugs and biological products during pregnancy and breast -\nfeeding. Another source of data could be from pregnancy exposure registries , w hich are conducted by some companies to \ncollect information on the effects of their approved drugs when those drugs are used by pregnant women to"}